View in EDS HTML Full Text PDF Full Text

Preoperative Co‐Mutation of BRAFV600E and TERT Promoter Predicts Tumor Aggressiveness and Recurrence‐Free Survival in Papillary Thyroid Carcinoma.

Saved in:

Bibliographic Details
Title:	Preoperative Co‐Mutation of BRAF^V600E and TERT Promoter Predicts Tumor Aggressiveness and Recurrence‐Free Survival in Papillary Thyroid Carcinoma.
Authors:	Deng, Chang^1,2 (AUTHOR), Cao, Yijia¹ (AUTHOR), Deng, Yuping¹ (AUTHOR), Chun, Lin³ (AUTHOR) 309062481@qq.com, Xinliang, Su¹ (AUTHOR) 201604@hospital.cqmu.edu.cn
Source:	Cancer Medicine. Jun2026, Vol. 15 Issue 6, p1-13. 13p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20457634
DOI:	10.1002/cam4.72029